Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitus

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1206卷 / 1期
关键词：
Glucose; Diabetes Mellitus; Heart Disease; Cardiovascular Event; Veteran Affair;
D O I：
10.2165/00128415-200812060-00016
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
    Hertzel C Gerstein
    Salim Yusuf
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 798 - 799
  • [2] Type 2 Diabetes mellitus itself does not increase Mortality or cardiovascular Risk
    Dovjak, Peter
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2018, 51 (08): : 947 - 948
  • [3] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    [J]. PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [4] Type 1 Diabetes Mellitus - Risk Factor for Cardiovascular Disease Morbidity and Mortality
    Chalakova, Tatyana
    Yotov, Yoto
    Tzotchev, Kaloyan
    Galcheva, Sonya
    Balev, Boyan
    Bocheva, Yana
    Usheva, Natalya
    Iotova, Violeta
    [J]. CURRENT DIABETES REVIEWS, 2021, 17 (01) : 37 - 54
  • [5] Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Kadoglou, N. P. E.
    Iliadis, F.
    Angelopoulou, N.
    Perrea, D.
    Liapis, C. D.
    Alevizos, M.
    [J]. DIABETIC MEDICINE, 2008, 25 (03) : 333 - 340
  • [6] Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
    Simo, Rafael
    Rodriguez, Angel
    Caveda, Elena
    [J]. CURRENT DRUG SAFETY, 2010, 5 (03) : 234 - 244
  • [7] DOES ASTHMA INCREASE CARDIOVASCULAR RISK IN TYPE 2 DIABETES?
    Ehrhart, M. D.
    Murray-Krezan, C.
    Qeadan, F.
    Burge, M. R.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (01) : 310 - 311
  • [8] Morbidity and mortality cardiovascular risk in dependence of type 2 diabetes duration
    Gimeno Orna, Jose Antonio
    Blasco Lamarca, Yolanda
    Campos Gutierrez, Belen
    Molinero Herguedas, Edmundo
    Lou Arnal, Luis Miguel
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2014, 26 (03): : 122 - 130
  • [9] Does Type 2 Diabetes Mellitus Increase Postoperative Complications in Patients Submitted to Cardiovascular Surgeries?
    Padovani, Caue
    da Costa Arruda, Regiane Maria
    Malosa Sampaio, Luciana Maria
    [J]. BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, 2020, 35 (03) : 249 - 253
  • [10] Does treatment with rosightazone increase cardiovascular risk of patients with type 2 diabetes melfitus?
    Gerstein, Hertzel C.
    Yusuf, Salim
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (12): : 798 - 799
12345